Clinical Trials Browser

Prostatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

Prostatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms

Adenocarcinoma, Pain, Pain, Postoperative, Prostatic Neoplasms

Renal Pelvis and Ureter Urothelial Carcinoma

Prostatic Neoplasms, Directly Observed Therapy

Kidney Neoplasms

Oligometastatic Renal Cell Carcinoma

Neoplasm Metastasis, Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Ovarian Germ Cell Cancer, Teratoma, Testicular Neoplasms, Endodermal Sinus Tumor

Urinary Bladder Neoplasms

Muscle Invasive Bladder Cancer

Carcinoma, Renal Cell, Wilms Tumor

Prostatic Neoplasms

Kidney Neoplasms

Kidney Neoplasms, Neoplasms

Carcinoma, Renal Cell, Kidney Neoplasms

Urinary Bladder Neoplasms, Urethral Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Clinical Trials

SUGAR

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

KEYNOTE-B15

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

INTerpath-005

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

KEYNOTE-866

KEYNOTE-905

GrandP/SPCG19

3 Tesla MRI in Patients With Bladder Cancer

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

RESTART

PE-PE

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer

SPCG-15

Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer

CONSERVE

CMM

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer